Introduction
Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide with continuously rising incidence rates in Western countries (1, 2) .
Although the principal clinical risk factors for HCC are well defined, molecular mechanisms contributing to tumor initiation and early progression are still not completely understood. In almost 90% of human malignancies, telomerase activation, characteristically mediated by re-expression of the rate-limiting catalytic subunit human telomerase reverse transcriptase (hTERT), has been observed as early event (3) . Telomerase is a cellular RNA-dependent DNA polymerase responsible for telomere maintenance and stabilization (4) . Telomeres are protective nucleoprotein structures at the end of linear chromosomes (5) . In normal somatic cells, hTERT is suppressed and consequently telomerase not active. Due to the endreplication problem, telomeres progressively shorten with every cell division until a critical length is reached and the cells enter senescence, a post-mitotic quiescent state (6) . Interestingly, several studies have recently demonstrated telomerase activation already in precancerous hepatic lesions (7) (8) (9) (10) . Based on these findings, telomerase activation has been proposed as an early prerequisite in hepatocarcinogenesis (11, 12) . In addition to a limitless replicative potential (immortalization), further genetic alterations are required for self-sufficiency in growth signals, insensitivity to anti-growth signals, effective evasion of apoptosis, and altered differentiation (13) .
In a considerable subset of patients with HCC, Wnt/β-catenin signaling is activated (14) . This pathway is, for example, crucial for the expansion and survival of 6 embryonic hepatoblasts (15, 16) . Recently, animal models also revealed that mobilization of hepatic stem cells during liver regeneration is associated with activation of Wnt/β-catenin signaling (17, 18) . β-Catenin is the key signaling molecule of the pathway. In the absence of activating ligands, a destruction complex consisting of axin, adenomatous polyposis coli protein (APC), and glycogen synthase kinase-3β (GSK-3β), phosphorylates β-catenin in the cytoplasm. Phosphorylated β-catenin undergoes degradation. In the activated state, Wnt binds to the membrane receptor frizzled and induces the dissociation of the destruction complex. β-Catenin escapes degradation and accumulates in the cytoplasm leading to increased translocation into the nucleus, where β-catenin initiates the expression of various target genes (17, 19, 20) . Activation of Wnt/β-catenin signaling, primarily caused by inactivating mutations in APC, AXIN1, or CTNNB1 (21, 22) , has recently been identified as a permissive pathway driving downstream transformation events in colorectal cancer (23) .
Interestingly, compared to the subgroup with TP53 mutations, liver cancers with activating mutations in CTNNB1 have relatively little chromosomal instability (24) , suggesting a driving role for this pathway also in hepatocarcinogenesis.
In this study, we employed previously characterized telomerase-immortalized human fetal hepatocytes (FH-hTERT) as cell culture model for untransformed proliferating human liver cells (25, 26) . To analyze the functional consequences of an aberrantly activated β-catenin-related transcription (CRT), we monitored cancer cell characteristics and transformation events in FH-hTERT following forced activation of β-catenin signaling. 
Material and Methods

Cell lines and plasmids
The local ethics committee approved utilization of FH-hTERT cells (approval number OB-034/06). FH-hTERT clones were used at population doubling (PD) 35 to 40 (just bypassing the senescence checkpoint) and 80 to 100. As described before, FHhTERT did not display a malignant phenotype (25) . As control human liver cancer cell lines, we cultured β-catenin-positive HepG2 and a Huh7 clone with a low baseline β-catenin expression ( Supplementary Fig. S1 ). Expression vectors for the wild-type and the constitutively active S33Y β-catenin mutant (pbcatwt and pbcatS33Y, respectively) were kindly provided by H. Clevers (Hubrecht Laboratory, Utrecht, Netherlands). The backbone vector pcDNA (Invitrogen, Karlsruhe, Germany) was transfected as vector control.
Cell culture and transfection
All cells were cultured in Dulbecco's Modified Eagle Medium with high glucose (4.5 g/L), 10% inactivated fetal bovine serum, and antibiotics (Invitrogen). For FH-hTERT, culture medium was additionally supplemented with 5 μg/mL insulin and 2.4 μg/mL hydrocortisone (Sigma-Aldrich, Seelze, Germany). Cells were nucleofected using Nucleofector Solution V (Amaxa, Köln, Germany) and program T30, and subsequently selected with Zeocin (Invitrogen) at 200 μg/mL for FH-hTERT and 50 μg/mL for Huh7 cells. ) (27) . In addition, cell lysates were extracted and 
Cell proliferation tests
To monitor cell proliferation, we performed serial cell counts in a standard 
Serum dependence and contact inhibition
To investigate serum dependence, cells were seeded in 96-well plates and serum was omitted in the following medium changes. Proliferation was monitored as Heidelberg, Germany). Cell cycle distribution of cells was determined using ModFit (Verity Software House, Topsham, ME).
Cytogenetic investigations
Multicolor karyotyping-fluorescence in situ hybridization (mFISH) was performed using the 24XCyte color kit for human chromosomes (MetaSystems, Altlussheim, Germany) according to the supplier's recommendations and as previously described (25) . We employed the Genome-Wide Human SNP Array 6.0 and the Genotyping Console 
Anchorage-independent growth
Soft agar colony-assays were performed as previously summarized (26) . 
Tumor formation in nude mice
Immunofluorescence of tumor samples
To visualize human cells within the observed tumors, cryostat sections were immunostained with a human-specific antibody recognizing the nuclear antigen SP-100 (kindly provided by H. Will, Heinrich-Pette-Institute, Hamburg, Germany). Expression levels were determined by comparative quantification (2 -ΔΔCt ) employing FH-hTERT pcDNA as calibrator (expression level = 1).
Statistical analysis
All experiments were performed in triplicates and with two to three repetitions. Data are presented as mean ± standard deviation (SD 
Results
Expression of dominant positive β-catenin
FH-hTERT display low Wnt/β-catenin pathway activity as determined with a dualluciferase reporter assay measuring β-catenin regulated gene expression (CRT).
Incubation with 40 mM LiCl, a GSK-3β inhibitor and chemical pathway activator, transiently enhanced CRT and demonstrated the possibility to activate β-catenin signaling in our cell clones (data not shown). Transfection of FH-hTERT with the constitutively active S33Y β-catenin mutant (pbcatS33Y) as well as with the wild-type control (pbcatwt), resulted in a significant increase in β-catenin transcripts determined by qPCR (Fig. 1A) . Following selection and expansion of Zeocin resistant cells, increased protein levels of β-catenin were observed in cells transfected with either of the two β-catenin expression plasmids. In comparison, only a faint β-catenin band was observed in FH-hTERT transfected with pcDNA (Fig. 1B) . In FH-hTERT stably transfected with pbcatS33Y (FH-hTERT pbcatS33Y), increased β-catenin levels resulted in a robust upregulation in downstream pathway activity (Fig. 1C) . CRT levels were not substantially increased in FH-hTERT pbcatwt, because the wild-type β-catenin is not translocated into the nucleus and does therefore not lead to target gene activation. pbcatS33Y) resulted in an accelerated cellular growth. This was confirmed by serial cell counts ( Fig. 2A) and a photometric assay monitoring proliferation more closely (Fig. 2B) . We also cultured the clones with 2% serum. Three days after seeding, we detected a significant difference in cell density between FH-hTERT pbcatS33Y and FH-hTERT pbcatwt. This difference reflects the accelerated growth in FH-hTERT pbcatS33Y (see above). However, serum-free culture significantly reduced cellular growth in FH-hTERT pbcatwt (Fig. 2C) , with a 20% reduction in cell density compared to cells cultured with 2% serum for three days. In contrast, serum depletion did not significantly affect cellular growth in FH-hTERT pbcatS33Y (Fig.   2C ). To determine changes in contact inhibition, we compared S-phase fractions in confluent cultures (3 days after reaching 100% confluency) with log-proliferating cultures (40-60% confluency). In FH-hTERT pcDNA, the S-phase fraction was reduced by more than 60% in confluent cultures compared to near-confluent cultures, which demonstrates effective growth inhibition by cell-to-cell contacts. In FH-hTERT pbcatS33Y, contact inhibition was almost completely eliminated, i.e., the S-phase fraction was reduced by only 10% (Fig. 2D) .
Clones with enhanced β-catenin signalling acquired translocations
Previous cytogenetic investigations demonstrated that FH-hTERT maintained a rather intact karyotype and did not acquire clonal structural chromosomal aberrations in long-term expansion culture (25) . In this study, cytogenetic monitoring of FHhTERT pbcatS33Y revealed acquisition of translocations, which were not observed in FH-hTERT control cells. Employing mFISH, 37 metaphase spreads were analyzed.
19 metaphases showed the translocations t(5;19)(q31;p11orq11) and t(10;11)(p13;q21) (Fig. 3A) . In addition, non clonal structural and numerical 
abnormalities were detected in 25 metaphases. Further analyses based on SNParrays exposed additional micro-amplifications and deletions on almost all chromosomes (Fig. 3B) . Taken together, these data suggest that FH-hTERT pbcatS33Y at least maintained the ability to proliferate despite chromosomal instability and potentially promoted the acquisition of structural chromosomal abnormalities.
Telomerase and β-catenin support a transformed phenotype
Anchorage-independent growth is an established in vitro marker for a malignant phenotype. Interestingly, after a few additional passages in cell culture, FH-hTERT pbcatS33Y developed the ability to generate colonies in soft agar (Table 1) .
Anchorage-independent growth was not observed in FH-hTERT pcDNA and FHhTERT pbcatwt. In addition, early passage FH-hTERT (PD 35 to 40, immediately after bypassing the senescence checkpoint) treated with pbcatS33Y also developed anchorage-independent growth capabilities; however, with a significantly lower frequency (Table 1) . To confirm the association between β-catenin activation and anchorage-independent growth, we also scored colony formation in Huh7 cells with and without illegitimate β-catenin activation. In this HCC cell line, expression of pbcatS33Y significantly induced colony growth in comparison to control cells. It should be noted, that colony formation was observed in malignant Huh7 cells after approximately 2 weeks, whereas colonies were seen in FH-hTERT pbcatS33Y only after a significantly longer latency period of seven weeks ( Table 1) .
As gold-standard proof for a transformed phenotype, FH-hTERT pbcatS33Y were transplanted subcutaneously into athymic nude mice. We transplanted Huh7 cells as 
a positive control. Tumor formation data is listed in Table 2 . As expected and as previously shown (26) , no tumor formation was detected in mice transplanted with control cells and FH-hTERT pbcatwt during a one-year observation period. However, after a mean latency period of 19.0 ± 3.0 weeks, tumors formed in all FH-hTERT pbcatS33Y transplantation sites (Fig. 4A) . Notably again, tumors formed with a significantly longer latency period compared to mice transplanted with Huh7 cells (Table 2 ). As further support for the oncogenic potential of forced β-catenin activation, tumor formation was also significantly accelerated in Huh7 cells following expression of pbcatS33Y (3.4 ± 0.9 weeks vs 7.7 ± 2.6 weeks, P <0.001). Huh7 S4 ). In this experiment, cells were not expanded until the telomere-dependent senescence checkpoint.
Cancer pathway profiling in derived tumors
In order to characterize the transformation process from immortalized cells to Expression of the tumor suppressor TP53 was not significantly altered in investigated tumor samples. However, S100 calcium binding protein A4 (S100A4), a strong plasminogen activator inhibitor, was upregulated by more than 2-log levels in 3 out of 4 assessed tumors (Fig. 5A) . The integrins ITGA1, ITGA2, and ITGA3, were all decreased in derived tumors, whereas the integrin ITGA4 (also known as CD49d) was 10-fold upregulated in FH-hTERT pbactS33Y and in derived tumors (Fig. 5B) .
Furthermore, the matrix metalloproteinase 1 (MMP1) displayed elevated and the plasminogen activator inhibitor SERPINE1 decreased expression levels in FHhTERT pbcatS33Y and in derived tumors. Urokinase-type plasminogen activator (PLAU) also plays a major role in cancer invasion and was induced by β-catenin activation in our model system with high expression in most investigated tumors (Fig.   5C ). Interestingly, vascular endothelial growth factor A (VEGFA) was not elevated in the majority of derived tumors. However, we observed an upregulation of insulin-like growth factor (IGF) in samples with low VEGFA and a strong suppression of thrombospondin 1 (THBS1), a strong inhibitor of neovascularization and tumorigenesis (Fig. 5D) . 
immortalized cells with forced β-catenin pathway activation has been functionally confirmed for human liver cells in our model system. To this regard, RNAi experiments in our cell clones established that hTERT and telomerase activity are not required to maintain proliferation in transformed cells. It still needs to be clarified, how frequently immortalized cells with forced β-catenin activation escape telomeredependent cell cycle arrest following telomerase inhibition.
Intriguingly, patients with HCC and β-catenin mutations frequently lack any significant fibrosis or cirrhosis (34) . In addition recent publications report induction of Wnt/β-catenin signaling by the hepatitis B virus X protein (35) and the core protein of the hepatitis C virus (36) as potential mechanism driving hepatocarcinogenesis in a noncirrhotic liver. These reports and our observation that β-catenin activation induces a cancer permissive phenotype in telomerase-immortalized cells, strongly support the notion that β-catenin dysregulation is one of the critical hits in the development of HCC. In the light of these findings, the proposed therapeutic application of β-catenin activation to promote progenitor cell-driven liver regeneration in hepatic failure or in small-for-size grafts following liver transplantation (34) should be explored with great caution.
In tumors derived form β-catenin-active telomerase-immortalized cells, cancer pathway profiling revealed upregulation of VEGFA or IGF1, MMP1, and PLAU.
MMPs play an important role in cancer cell invasion by degrading extracellular matrices. For instance, HCC cells constitutively expressing MMPs can promote cells to invade through matrix gel in vitro and this MMP-dependent invasion is increased in response to hepatocyte growth factor and is blocked by MMP inhibitors (37). 
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